After Hours Summary: OTEX +4.8%, BONE +4.2%, MSFT +3.7%, DGII -11.2%, RMD -9.1%, IGT -7.9%, ISRG -4.1% following earnings/guidance
After Hours Gainers:
* Companies trading higher in after hours in reaction to earnings: OTEX +4.8%, BONE +4.2%, MSFT +3.7%, MSCC +3.5%, ALTR +2.8%, DFS +2.7%, ETFC +2.7%, JNPR +2.3%, SBUX +1.0%, KLAC +0.7%, CPWR +0.1%
* Companies trading higher in after hours in reaction to news: - BDSI +27.2% (Endo Health and BioDeliver Sciences announce positive top-line results from the Phase 3 clinical trial of BEMA buprenorphine in opioid naive patients with chronic pain), - FTNT +3.0% (to replace Harris Teeter Supermarkets (HTSI) in the S&P MidCap 400), - IMOS +2.7% (DLS Capital Management discloses 5.07% passive stake), - INFI +2.2% (reported phase 1 data of IPI-145 at sixth annual t-cell lymphoma forum; 38% response rate in patients with t-cell lymphomas, suggesting broad potential of IPI-145 in blood cancers),
After Hours Losers:
* Companies trading lower in after hours in reaction to earnings: DGII -11.2%, RMD -9.1%, IGT -7.9%, COVS -6.5%, ISRG -4.1%, AMCC -2.2%, HEOP -2.0%, DLB -1.3%, SHOR -1.0%, INFA -0.9%, SYNA -0.9%, MXIM -0.1%
* Companies trading lower in after hours in reaction to news: - ATOS -18.8% (announced public offering of common stock and warrants), - KIPS -14.3% (announced public offering of common stock), - TNXP -4.3% (announced proposed public offering of common stock, no amount given), - CST -3.9% (updated Q4 guidance, provided cautious outlook), - PGNX -3.4% (filed for $150 mln mixed securities shelf offering), - GNVC -2.0% (filed for $75 mln mixed securities shelf offering)